Advertisement

Topics

Companies Related to "Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer" [Most Relevant Company Matches] RSS

11:15 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Temozolomide Maintenance Therapy Following Induction Chemotherapy Extensive Stage" Companies 1–25 of 3,800+

Relevant

Xstrahl

Xstrahl is a leading designer and manufacturer of X-ray systems for use in cancer and dermatology treatments and radiation biology research, providing complete solutions for all X-ray therapy and research applications. Xstrahl has more than 15 years’ experience supporting the X-ray therapy requirements of healthcare providers around the world, from in...


TriLink BioTechnologies

TriLink offers cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. TriLink specializes in the modification of oligonucleotides and nucleoside triphosphates. We provide a wide range of services from radioactive labeling to conjugation to custom research.TriLink manufactures the world’s most extensive line of special...

Sonrgy, Inc.

Sonrgy is a preclinical stage biotechnology company based in San Diego, California that is developing a targeted chemotherapy delivery platform to improve survival and quality of life for millions of cancer patients. Sonrgy’s tiny nanocarriers safely transport potent chemotherapy drugs to cancer tumors and release high doses on command in response to a focus...


ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

Myonexus Therapeutics

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a leader in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics’ pipeline includes three clinical stage g...

EUSA Pharma Inc

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...

Bellingham Regional Breast Center

The Bellingham Regional Breast Center provides comprehensive diagnosis and treatment for all breast disorders. Services include early diagnosis; risk analysis with genetic counseling and testing; treatment with surgery, radiation therapy, chemotherapy, endocrine therapy, targeted therapies, and immune therapy; and supportive care including counseling, phys...

EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...

TriLink BioTechnologies Incorporated

Specialty Oligonucleotides and Nucleoside Triphosphates TriLink offers cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. TriLink specializes in the modification of oligonucleotides and nucleoside triphosphates. We provide a wide range of services from radioactive labeling to conjugation to custom research. TriLink ...

Emmerex

Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...

Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...

OPS SYSTEMS INC

OPS Systems provides strategic data management software and preventive maintenance software solutions.OPS family of products provides Data Management software for water, wastewater and energy plant operations. Our software manages your data, does your reports including NPDES and State DMR's, outputs graphs to analyze and predict process performance, and provides process modeling routines.JOB Cal...

OncoSec Medical Inc.

OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize ...

Gulmay Medical Limited

Gulmay Medical Limited commenced operation in 1995 to develop, design, manufacture and market x-ray therapy equipment specifically to the medical market and now has an installed base of superficial and orthovoltage equipment in over 100 hospitals worldwide.Gulmay Medical customers benefit from the groups integrated development philosophy. Offering a turnkey approach for therapy centres involving a...

Pro Chem, Inc.

Founded in 1969, we are one of America's leading suppliers of industrial maintenance and sanitation products. When it comes to solving a maintenance, repair or sanitation problem we have the state-of-the-art solution. Long ago we realized our customers wanted a reliable source of superior quality, cost-effective products that were environmentally friendly. They also wanted a source that maintained...

Therapy Source, Inc.

Therapy Source, a premier therapy staffing provider, offers highly qualified speech, occupational, physical, psychological and related therapy services to educational and healthcare organizations. For more information on Therapy Source, visit www.txsource.net or call toll free at 866-783-5301.

Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...

bioAffinity Technologies

bioAffinity Technologies, Inc. (www.bioaffinitytech.com) is a privately held development-stage company advancing proprietary screening and early‐stage diagnostic technology applicable to a broad range of cancers. The Company holds extensive U.S. and international patents that allow for global commercialization of its technology.

bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. (www.bioaffinitytech.com) is a privately held development-stage company advancing proprietary screening and early‐stage diagnostic technology applicable to a broad range of cancers. The Company holds extensive U.S. and international patents that allow for global commercialization of its technology.

DiaTech Oncology

DiaTech Oncology is a privately held clinical pathology laboratory that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. DiaTech utilizes a patented technology called the Microculture Kinetic (MiCK) assay, which measures apoptosis (cell death) induced in a specific patient’s...

OncoWell, LLC

OncoWell, LLC, headquartered in New York, NY, provides complementary products and resources to patients undergoing cancer treatment. The company’s first offering, OncoWellCE, is a concentrated enzyme product to support patient wellness while undergoing chemotherapy or radiation therapy. OncoWell, LLC was founded in 2012 by James Nicholls, Peter Jenkin...

Nodality, Inc.

Nodality develops and commercializes the next generation of personal diagnostic tests by characterizing cell signaling pathways in defined cellular sub-populations of malignant and normal cells. The South San Francisco based company applies proprietary multiparametric Single Cell Network Profiling (SCNP) technology to develop highly predictive biological ...

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is the only company in the biotechnology reagent business that primarily focuses on gene therapy related products.

Salmedix Incorporated

Salmedix, Inc. is a San Diego-based biopharmaceutical company formed to in-license, develop and commercialize new cancer drugs, with an initial focus on hematologic cancers. Salmedix is developing novel therapies designed to be more effective and better tolerated than traditional cytotoxic cancer chemotherapy. The Company has licensed a portfolio of intellectual property invented in the laborator...

GammaCan

GammaCan is a biopharmaceutical company focused on clinical-phase development and commercialization. GammaCan’s initial therapy under development is a first-in-class anti-cancer immunotherapy aimed at preventing metastasis (the spread of cancer to other parts of the body) of a variety of cancers. GammaCan’s first product was entered to phase-II clinical trials.GammaCan’s innovative treatment...


More From BioPortfolio on "Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks